Vienna NGO Committee on Drugs (VNGOC): Good afternoon to everybody. Thank you very much for coming today for this informal dialogue. We would also like to thank our panel from OHCHR, UNDP and UNAIDS for being here together today and for continuing this tradition of informal dialogues with civil society. On behalf of the Vienna …
Harm Reduction International
Informal NGO Dialogue with the Acting UNODC Executive Director
Vienna NGO Committee on Drugs (VNGOC): Good morning, everybody. Thank you for joining this informal dialogue with the Acting Executive Director of UNODC, John Brandolino, and thank you for accepting our invitation. This has become a long-standing tradition to exchange views and perspectives with civil society organisations here in Vienna, and we really appreciate this …
Informal NGO Dialogue with WHO
VNGOC: Good morning, and welcome to the informal dialogue with the WHO. First of all, I’d like to thank you on behalf of the Vienna NGO Committee and to thank the representatives of the World Health Organization for being here today to answer all the questions from civil society. Also, I’d like to say thank …
CND Thematic Discussions on the Implementation of All International Drug Policy Commitments, following-up to the 2019 Ministerial Declaration – 30 September 2025 – Afternoon Session
CND Thematic Discussions on Strengthening Public Health Responses to Drug Use Session 2: Drug Treatment and Health Services Falling Short of Meeting Needs; Increase in Deaths Related to Drug Use Chair: We begin the afternoon session with a discussion on the topic of Treatment and health services – falling short of meeting needs, increase in deaths …
Plenary – Thursday morning session
Item 6. Follow-up to the implementation at the national, regional and international levels of all commitments, as reflected in the Ministerial Declaration of 2019, to address and counter the world drug problem (continued) United States: The US takes the floor to address statements made yesterday regarding the mandate of the INCB which we do not …
Plenary — Wednesday morning session
Item 5. Implementation of the international drug control treaties (continued) (a) Changes in the scope of control of substances Chair: First, Commission will consider recommendations of WHO on 4 substances, namely: (a) Whether or not it wishes to include N-pyrrolidino protonitazene in Schedule I of the 1961 Convention as amended; (b) Whether or not it …